AKT1 and cancer: To explore the mechanisms underlying the inhibition of melanoma cell proliferation by TMEM16A knockdown, we examined the downstream signaling pathways contributing to cancer growth induced by TMEM16A overexpression, such as the MEK/ERK and AKT pathways.3